Joint ACA | ACVP | PPSI Statement on COVID-19

UPDATED: March 24, 2020

Effective March 25, 2020, our office building will be closed; all staff will be working from home during our regular business hours, Monday – Thursday, 8:00 am-5:00 pm and 8:00 am-noon on Friday. We will not be answering the phones, but will be responding to emails using the contact form.

The ACA has cancelled training classes through May 31. At this time, registration for courses scheduled after June 1 remains open. We are working to reschedule cancelled courses for June and July so that we will be able to continue to provide needed compounding training for pharmacy professionals. We are also working to provide additional online training materials and accredited CE for pharmaceutical compounding and other topics on our  Online CE Portal.

We have suspended registration until mid-April for the 2020 Veterinary Pharmacy Conference scheduled for June 25-27 as we evaluate our options.

UPDATED: March 12, 2020

We understand and support the difficult decision made yesterday by the American Pharmacists Association to cancel their upcoming Annual Meeting and Expo. This cancellation includes all related conference activites, including the PPSI Public Health Town Hall Breakfast scheduled for Sunday, March 22. We are currently evaluating our options for rescheduling this event at a later date. 

Registration for the ACVP Veterinary Pharmacy Conference, June 25-27, in Raleigh, North Carolina is still open. We are monitoring the situation and exploring other options. We anticipate making a decision regarding the feasibility of hosting a live conference by mid-April.

March 10, 2020

At the American College of Apothecaries, American College of Veterinary Pharmacists, and Pharmacists Planning Services, Inc., public health and safety is our top priority.

While we are operating as usual, we are also working on contingency plans to be prepared for changing circumstances. We are actively following the Centers for Disease Control (CDC) and local state departments of health as well as local public health authorities so we can respond quickly to any shifts in their recommendations.

What are ACA , ACVP, and PPSI doing in response to COVID-19?
Our organizations are monitoring the situation closely.

As of today, our plan is to still hold our upcoming events as scheduled, including compounding training courses at the National Training Laboratory in Bartlett, Tennessee and the ACVP Veterinary Pharmacy Conference in Raleigh, North Carolina.

Due to the evolving nature of this situation, cancellations may have to be made with short notice, for instance in the case of a public health directive. We will do our best to contact all those affected as quickly as possible.

What steps can pharmacists take to prevent the spread of COVID-19?
Recommend to your patients and staff to follow all of the steps recommended by the CDC. The same simple steps that prevent the spread of ordinary flu viruses work against COVID-19 and other illnesses:

  • Wash your hands often with soap and water for at least 20 seconds. Use an alcohol-based hand sanitizer if soap and water are not available.
  • Cough into a tissue or your elbow (not your hand). Then throw the tissue away and wash hands.
  • Avoid touching your eyes, nose, or mouth with unwashed hands.
  • Avoid contact with people who are sick.
  • Stay home when you are sick, with a temperature above 100.0 F (38.7 C) or do not feel well, appear weak or ill.
  • Consult your health care provider if you have special health conditions that put you at increased risk.

Be a Source of Comfort and Calm for the Public
The CDC has developed a helpful resource for Healthcare Professionals that covers clinical features, infection control, and guidances for evaluating and reporting persons under investigation (PUI).

Additional information and resources about the Covid-19:

2020 CDC Clinician Outreach and Communication Activity (COCA)

COCA prepares clinicians to respond to emerging health threats and public health emergencies by communicating relevant, timely information related to disease outbreaks, disasters, terrorism events, and other health alerts.

Calls/Webinars Information, Summaries, & Slide Sets

Click on the titles below for more information.

Title: Underlying Medical Conditions and People at Higher Risk for Coronavirus Disease 2019 (COVID-19)

Date: Friday, March 27, 2020

Title: COVID-19 Update: Optimization Strategies for Healthcare Personal Protective Equipment (PPE)

Date: Wednesday, March 25, 2020

From USP Healthcare Quality & Safety Team

UPDATED: March 18, 2020

In light of the rapidly evolving COVID-19 pandemic, the demand for garbing and personal protective equipment (PPE) and alcohol-based hand sanitizer is expected to outpace available supply. During this pandemic, USP supports State Boards and other regulators using risk-based enforcement discretion related to the implementation of USP compounding standards and the compounding of alcohol-based hand sanitizers for consumer use.

The USP Compounding Expert Committee developed the following informational resources that may be of assistance during this public health emergency:

From the FDA: Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency

UPDATED: March 14, 2020

Due to the Coronavirus Disease 2019 (COVID-19) pandemic, the Food and Drug Administration (FDA or Agency) has received a number of queries concerning compounding of alcohol-based hand sanitizers.   Read or download the guidance here: